Emerging Disease News and Research

RSS
New research aims to control transmission of infectious diseases

New research aims to control transmission of infectious diseases

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Vical extends relationship with U.S. NMRC for emerging disease vaccine platform

Vical extends relationship with U.S. NMRC for emerging disease vaccine platform

Infinity provides guidance on anticipated pipeline and business goals for 2011

Infinity provides guidance on anticipated pipeline and business goals for 2011

Infinity named to NASDAQ Global Select Market

Infinity named to NASDAQ Global Select Market

Infinity extends global strategic alliance with Mundipharma for development, commercialization of IPI-926

Infinity extends global strategic alliance with Mundipharma for development, commercialization of IPI-926

Researchers synthesize iron compounds that inhibit growth of Mycobacterium tuberculosis

Researchers synthesize iron compounds that inhibit growth of Mycobacterium tuberculosis

Infinity announces enrollment in IPI-926 Phase 1b/2 clinical trial for pancreatic cancer

Infinity announces enrollment in IPI-926 Phase 1b/2 clinical trial for pancreatic cancer

Infinity announces Phase 1b/2 clinical trial of IPI-926 in patients with metastatic pancreatic cancer

Infinity announces Phase 1b/2 clinical trial of IPI-926 in patients with metastatic pancreatic cancer

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

New tools could help detect wildlife disease outbreaks

New tools could help detect wildlife disease outbreaks

Journal of Clinical Oncology publishes IPI-504 Phase 2 study results

Journal of Clinical Oncology publishes IPI-504 Phase 2 study results

Infinity announces preliminary results of IPI-926 Phase 1 study in patients with solid tumors

Infinity announces preliminary results of IPI-926 Phase 1 study in patients with solid tumors

Knowledge about ecology of disease limits spread of infection

Knowledge about ecology of disease limits spread of infection

Study explains importance of identifying global pandemic risk factors to predict spread of diseases

Study explains importance of identifying global pandemic risk factors to predict spread of diseases

Albert Einstein College of Medicine receives grant to study role of proteins in health and disease

Albert Einstein College of Medicine receives grant to study role of proteins in health and disease

Infinity Pharmaceuticals to present IPI-926 inhibitor Phase 1 data at ESMO Congress

Infinity Pharmaceuticals to present IPI-926 inhibitor Phase 1 data at ESMO Congress

Infinity reports $18.4 million total revenue for second-quarter 2010

Infinity reports $18.4 million total revenue for second-quarter 2010

Infinity obtains global rights to Intellikine's portfolio of inhibitors of delta and gamma isoforms of PI3K

Infinity obtains global rights to Intellikine's portfolio of inhibitors of delta and gamma isoforms of PI3K